20250195652. Method Engineering Innate (UCL BUSINESS)
Method for Engineering Innate-Like Lymphocytes
Abstract: the present invention relates to methods for introducing nucleic acid into innate-like lymphocytes, including gamma delta t cells, with a lentiviral vector; populations or compositions of genetically engineered innate-like lymphocytes; and methods for treating or preventing disease.
Inventor(s): Jonathan Fisher, Marta Barisa, Daniel Fowler, John Counsell
CPC Classification: A61K40/11 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms ; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles ; soap compositions ))
Search for rejections for patent application number 20250195652